AF
ETNB

Amalgamated Financial’s 89bio ETNB Stock Holding History

Amalgamated Financial’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$5K Buy
+1,226
New +$7.9K ﹤0.01% 2962

Other funds holding ETNB

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PHS
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

Amalgamated Financial's ETNB Position: Q1 2022 in Review

Amalgamated Financial opened a new position in 89bio (ETNB) in Q1 2022: 1,226 shares worth $5K. The stake represents ﹤0.01% of the portfolio and ranks #2962 among its holdings.

69 funds tracked by Wall St. Rank hold ETNB as of Q1 2022.

  • Amalgamated Financial held 1,226 shares of 89bio worth $5K as of Q1 2022.
  • 89bio was a new Amalgamated Financial position in Q1 2022.
  • 89bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2962 holding.
  • 69 funds tracked by Wall St. Rank held 89bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.